Global Diagnostic Specialty Enzymes Market to Reach $1.22 Billion by 2027 at a CAGR 8.1%


Dublin, Sept. 16, 2022 (GLOBE NEWSWIRE) -- The "Global Diagnostic Specialty Enzymes Market (2022-2027) by Type, Application, Source, Form, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Diagnostic Specialty Enzymes Market is estimated to be worth USD 832.06 million in 2022, and is expected to reach USD 1,228.24 million by 2027, growing at a CAGR of 8.1%.

Market Segmentation

The Global Diagnostic Specialty Enzymes Market is segmented based on Type, Application, Source, Form, and Geography.

  • By Type, the market is classified into Carbohydrases , Proteases , Lipases , Polymerases & Nucleases , Other Enzymes.
  • By Application, the market is classified into Pharmaceuticals , Research & Biotechnology , Diagnostics , and Biocatalysts.
  • By Source, the market is classified into Microorganisms , Plants, and Animals.
  • By Form, the market is classified into Liquid and Dry.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Diagnostic Specialty Enzymes Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The Global Diagnostic Specialty Enzymes Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.

Why Buy This Report?

  • The report offers a comprehensive evaluation of the Global Diagnostic Specialty Enzymes Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario within the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules & regulations imposed on this sector across various geographies.
  • The report also contains competitive analysis using 'Positioning Quadrants'; a proprietary competitive positioning tool.

Report Highlights

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Market Dynamics

Drivers

  • Growing Demand for Non-Harmful Biological Catalysts in Pharmaceuticals & Diagnostics
  • Increasing Clinical In the Vitro Diagnostics Industry
  • Rising Use of Enzyme-based Pharmaceutical Drug Formulations to Treat Chronic Disease

Restraints

  • Lack of Harmonization in the Regulatory Framework
  • High Adoption Costs Involved For Small & Medium Enterprises

Opportunities

  • Technological Innovations and Wide Industry Scope in the Enzymes Market
  • Massive Funding in the Biotechnology Sector and Momentum Rising in Molecular Diagnostics

Challenges

  • Concern Over Quality Of Enzymes Used In Pharmaceuticals & Diagnostics

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Diagnostic Specialty Enzymes Market, by Type
6.1 Introduction
6.2 Carbohydrases
6.3 Proteases
6.4 Lipases
6.5 Polymerases & Nucleases
6.6 Other Enzymes

7 Global Diagnostic Specialty Enzymes Market, by Application
7.1 Introduction
7.2 Pharmaceuticals
7.3 Research & Biotechnology
7.4 Diagnostics
7.5 Biocatalysts

8 Global Diagnostic Specialty Enzymes Market, by Source
8.1 Introduction
8.2 Microorganisms
8.3 Plants
8.4 Animals

9 Global Diagnostic Specialty Enzymes Market, by Form
9.1 Introduction
9.2 Liquid
9.3 Dry

10 Americas' Diagnostic Specialty Enzymes Market

11 Europe's Diagnostic Specialty Enzymes Market

12 Middle East and Africa's Diagnostic Specialty Enzymes Market

13 APAC's Diagnostic Specialty Enzymes Market

14 Competitive Landscape

15 Company Profiles

16 Appendix

Companies Mentioned

  • Advanced Enzymes
  • Amano Enzyme
  • Amicogen
  • Antozyme Biotech
  • BASF
  • BBI Solutions
  • Biocatalysts
  • Biovet
  • Codexis
  • Dupont
  • Dyadic International
  • Enzyme Development Corporation
  • Merck
  • NAGASE & Co.
  • Novozymes
  • Roche Holding
  • Sanofi
  • Sekisui Diagnostics
  • Specialty Enzymes & Probiotics

For more information about this report visit https://www.researchandmarkets.com/r/r5lewl

Attachment

 
Global Diagnostic Specialty Enzymes Market

Contact Data